Report Overview
Inactivated vaccines for pets are vaccines made from killed pathogens.
The global Pet Inactivated Vaccine market size was estimated at USD 490.20 million in 2023 and is projected to reach USD 800.48 million by 2032, exhibiting a CAGR of 5.60% during the forecast period.
North America Pet Inactivated Vaccine market size was estimated at USD 140.29 million in 2023, at a CAGR of 4.80% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Pet Inactivated Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pet Inactivated Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pet Inactivated Vaccine market in any manner.
Global Pet Inactivated Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer
Market Segmentation (by Type)
Obtained by Heat Killing
Killed by Chemical Methods such as Formaldehyde
Obtained by Radiation Killing
Market Segmentation (by Application)
Dog
Cat
Dird
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pet Inactivated Vaccine Market
Overview of the regional outlook of the Pet Inactivated Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pet Inactivated Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pet Inactivated Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pet Inactivated Vaccine
1.2 Key Market Segments
1.2.1 Pet Inactivated Vaccine Segment by Type
1.2.2 Pet Inactivated Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pet Inactivated Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Pet Inactivated Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Pet Inactivated Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pet Inactivated Vaccine Market Competitive Landscape
3.1 Global Pet Inactivated Vaccine Sales by Manufacturers (2019-2025)
3.2 Global Pet Inactivated Vaccine Revenue Market Share by Manufacturers (2019-2025)
3.3 Pet Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pet Inactivated Vaccine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Pet Inactivated Vaccine Sales Sites, Area Served, Product Type
3.6 Pet Inactivated Vaccine Market Competitive Situation and Trends
3.6.1 Pet Inactivated Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pet Inactivated Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pet Inactivated Vaccine Industry Chain Analysis
4.1 Pet Inactivated Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pet Inactivated Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pet Inactivated Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pet Inactivated Vaccine Sales Market Share by Type (2019-2025)
6.3 Global Pet Inactivated Vaccine Market Size Market Share by Type (2019-2025)
6.4 Global Pet Inactivated Vaccine Price by Type (2019-2025)
7 Pet Inactivated Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pet Inactivated Vaccine Market Sales by Application (2019-2025)
7.3 Global Pet Inactivated Vaccine Market Size (M USD) by Application (2019-2025)
7.4 Global Pet Inactivated Vaccine Sales Growth Rate by Application (2019-2025)
8 Pet Inactivated Vaccine Market Consumption by Region
8.1 Global Pet Inactivated Vaccine Sales by Region
8.1.1 Global Pet Inactivated Vaccine Sales by Region
8.1.2 Global Pet Inactivated Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Pet Inactivated Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pet Inactivated Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pet Inactivated Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pet Inactivated Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pet Inactivated Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Pet Inactivated Vaccine Market Production by Region
9.1 Global Production of Pet Inactivated Vaccine by Region (2019-2025)
9.2 Global Pet Inactivated Vaccine Revenue Market Share by Region (2019-2025)
9.3 Global Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Pet Inactivated Vaccine Production
9.4.1 North America Pet Inactivated Vaccine Production Growth Rate (2019-2025)
9.4.2 North America Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Pet Inactivated Vaccine Production
9.5.1 Europe Pet Inactivated Vaccine Production Growth Rate (2019-2025)
9.5.2 Europe Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Pet Inactivated Vaccine Production (2019-2025)
9.6.1 Japan Pet Inactivated Vaccine Production Growth Rate (2019-2025)
9.6.2 Japan Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Pet Inactivated Vaccine Production (2019-2025)
9.7.1 China Pet Inactivated Vaccine Production Growth Rate (2019-2025)
9.7.2 China Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Bayer Healthcare
10.1.1 Bayer Healthcare Pet Inactivated Vaccine Basic Information
10.1.2 Bayer Healthcare Pet Inactivated Vaccine Product Overview
10.1.3 Bayer Healthcare Pet Inactivated Vaccine Product Market Performance
10.1.4 Bayer Healthcare Business Overview
10.1.5 Bayer Healthcare Pet Inactivated Vaccine SWOT Analysis
10.1.6 Bayer Healthcare Recent Developments
10.2 Vetoquinol S.A
10.2.1 Vetoquinol S.A Pet Inactivated Vaccine Basic Information
10.2.2 Vetoquinol S.A Pet Inactivated Vaccine Product Overview
10.2.3 Vetoquinol S.A Pet Inactivated Vaccine Product Market Performance
10.2.4 Vetoquinol S.A Business Overview
10.2.5 Vetoquinol S.A Pet Inactivated Vaccine SWOT Analysis
10.2.6 Vetoquinol S.A Recent Developments
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Pet Inactivated Vaccine Basic Information
10.3.2 Boehringer Ingelheim Pet Inactivated Vaccine Product Overview
10.3.3 Boehringer Ingelheim Pet Inactivated Vaccine Product Market Performance
10.3.4 Boehringer Ingelheim Pet Inactivated Vaccine SWOT Analysis
10.3.5 Boehringer Ingelheim Business Overview
10.3.6 Boehringer Ingelheim Recent Developments
10.4 Ceva
10.4.1 Ceva Pet Inactivated Vaccine Basic Information
10.4.2 Ceva Pet Inactivated Vaccine Product Overview
10.4.3 Ceva Pet Inactivated Vaccine Product Market Performance
10.4.4 Ceva Business Overview
10.4.5 Ceva Recent Developments
10.5 Eli Lilly
10.5.1 Eli Lilly Pet Inactivated Vaccine Basic Information
10.5.2 Eli Lilly Pet Inactivated Vaccine Product Overview
10.5.3 Eli Lilly Pet Inactivated Vaccine Product Market Performance
10.5.4 Eli Lilly Business Overview
10.5.5 Eli Lilly Recent Developments
10.6 Heska
10.6.1 Heska Pet Inactivated Vaccine Basic Information
10.6.2 Heska Pet Inactivated Vaccine Product Overview
10.6.3 Heska Pet Inactivated Vaccine Product Market Performance
10.6.4 Heska Business Overview
10.6.5 Heska Recent Developments
10.7 Merck Animal Health
10.7.1 Merck Animal Health Pet Inactivated Vaccine Basic Information
10.7.2 Merck Animal Health Pet Inactivated Vaccine Product Overview
10.7.3 Merck Animal Health Pet Inactivated Vaccine Product Market Performance
10.7.4 Merck Animal Health Business Overview
10.7.5 Merck Animal Health Recent Developments
10.8 Merial (Sanofi)
10.8.1 Merial (Sanofi) Pet Inactivated Vaccine Basic Information
10.8.2 Merial (Sanofi) Pet Inactivated Vaccine Product Overview
10.8.3 Merial (Sanofi) Pet Inactivated Vaccine Product Market Performance
10.8.4 Merial (Sanofi) Business Overview
10.8.5 Merial (Sanofi) Recent Developments
10.9 Virbac
10.9.1 Virbac Pet Inactivated Vaccine Basic Information
10.9.2 Virbac Pet Inactivated Vaccine Product Overview
10.9.3 Virbac Pet Inactivated Vaccine Product Market Performance
10.9.4 Virbac Business Overview
10.9.5 Virbac Recent Developments
10.10 Pfizer
10.10.1 Pfizer Pet Inactivated Vaccine Basic Information
10.10.2 Pfizer Pet Inactivated Vaccine Product Overview
10.10.3 Pfizer Pet Inactivated Vaccine Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
11 Pet Inactivated Vaccine Market Forecast by Region
11.1 Global Pet Inactivated Vaccine Market Size Forecast
11.2 Global Pet Inactivated Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pet Inactivated Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pet Inactivated Vaccine Market Size Forecast by Region
11.2.4 South America Pet Inactivated Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Pet Inactivated Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Pet Inactivated Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Pet Inactivated Vaccine by Type (2025-2032)
12.1.2 Global Pet Inactivated Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Pet Inactivated Vaccine by Type (2025-2032)
12.2 Global Pet Inactivated Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Pet Inactivated Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pet Inactivated Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pet Inactivated Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Pet Inactivated Vaccine Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Pet Inactivated Vaccine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Pet Inactivated Vaccine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Pet Inactivated Vaccine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Inactivated Vaccine as of 2022)
Table 10. Global Market Pet Inactivated Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Pet Inactivated Vaccine Sales Sites and Area Served
Table 12. Manufacturers Pet Inactivated Vaccine Product Type
Table 13. Global Pet Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pet Inactivated Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pet Inactivated Vaccine Market Challenges
Table 22. Global Pet Inactivated Vaccine Sales by Type (K MT)
Table 23. Global Pet Inactivated Vaccine Market Size by Type (M USD)
Table 24. Global Pet Inactivated Vaccine Sales (K MT) by Type (2019-2025)
Table 25. Global Pet Inactivated Vaccine Sales Market Share by Type (2019-2025)
Table 26. Global Pet Inactivated Vaccine Market Size (M USD) by Type (2019-2025)
Table 27. Global Pet Inactivated Vaccine Market Size Share by Type (2019-2025)
Table 28. Global Pet Inactivated Vaccine Price (USD/MT) by Type (2019-2025)
Table 29. Global Pet Inactivated Vaccine Sales (K MT) by Application
Table 30. Global Pet Inactivated Vaccine Market Size by Application
Table 31. Global Pet Inactivated Vaccine Sales by Application (2019-2025) & (K MT)
Table 32. Global Pet Inactivated Vaccine Sales Market Share by Application (2019-2025)
Table 33. Global Pet Inactivated Vaccine Sales by Application (2019-2025) & (M USD)
Table 34. Global Pet Inactivated Vaccine Market Share by Application (2019-2025)
Table 35. Global Pet Inactivated Vaccine Sales Growth Rate by Application (2019-2025)
Table 36. Global Pet Inactivated Vaccine Sales by Region (2019-2025) & (K MT)
Table 37. Global Pet Inactivated Vaccine Sales Market Share by Region (2019-2025)
Table 38. North America Pet Inactivated Vaccine Sales by Country (2019-2025) & (K MT)
Table 39. Europe Pet Inactivated Vaccine Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Pet Inactivated Vaccine Sales by Region (2019-2025) & (K MT)
Table 41. South America Pet Inactivated Vaccine Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Pet Inactivated Vaccine Sales by Region (2019-2025) & (K MT)
Table 43. Global Pet Inactivated Vaccine Production (K MT) by Region (2019-2025)
Table 44. Global Pet Inactivated Vaccine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Pet Inactivated Vaccine Revenue Market Share by Region (2019-2025)
Table 46. Global Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Bayer Healthcare Pet Inactivated Vaccine Basic Information
Table 52. Bayer Healthcare Pet Inactivated Vaccine Product Overview
Table 53. Bayer Healthcare Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Bayer Healthcare Business Overview
Table 55. Bayer Healthcare Pet Inactivated Vaccine SWOT Analysis
Table 56. Bayer Healthcare Recent Developments
Table 57. Vetoquinol S.A Pet Inactivated Vaccine Basic Information
Table 58. Vetoquinol S.A Pet Inactivated Vaccine Product Overview
Table 59. Vetoquinol S.A Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Vetoquinol S.A Business Overview
Table 61. Vetoquinol S.A Pet Inactivated Vaccine SWOT Analysis
Table 62. Vetoquinol S.A Recent Developments
Table 63. Boehringer Ingelheim Pet Inactivated Vaccine Basic Information
Table 64. Boehringer Ingelheim Pet Inactivated Vaccine Product Overview
Table 65. Boehringer Ingelheim Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Boehringer Ingelheim Pet Inactivated Vaccine SWOT Analysis
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Recent Developments
Table 69. Ceva Pet Inactivated Vaccine Basic Information
Table 70. Ceva Pet Inactivated Vaccine Product Overview
Table 71. Ceva Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Ceva Business Overview
Table 73. Ceva Recent Developments
Table 74. Eli Lilly Pet Inactivated Vaccine Basic Information
Table 75. Eli Lilly Pet Inactivated Vaccine Product Overview
Table 76. Eli Lilly Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Recent Developments
Table 79. Heska Pet Inactivated Vaccine Basic Information
Table 80. Heska Pet Inactivated Vaccine Product Overview
Table 81. Heska Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Heska Business Overview
Table 83. Heska Recent Developments
Table 84. Merck Animal Health Pet Inactivated Vaccine Basic Information
Table 85. Merck Animal Health Pet Inactivated Vaccine Product Overview
Table 86. Merck Animal Health Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Merck Animal Health Business Overview
Table 88. Merck Animal Health Recent Developments
Table 89. Merial (Sanofi) Pet Inactivated Vaccine Basic Information
Table 90. Merial (Sanofi) Pet Inactivated Vaccine Product Overview
Table 91. Merial (Sanofi) Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Merial (Sanofi) Business Overview
Table 93. Merial (Sanofi) Recent Developments
Table 94. Virbac Pet Inactivated Vaccine Basic Information
Table 95. Virbac Pet Inactivated Vaccine Product Overview
Table 96. Virbac Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Virbac Business Overview
Table 98. Virbac Recent Developments
Table 99. Pfizer Pet Inactivated Vaccine Basic Information
Table 100. Pfizer Pet Inactivated Vaccine Product Overview
Table 101. Pfizer Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. Global Pet Inactivated Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global Pet Inactivated Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Pet Inactivated Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America Pet Inactivated Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Pet Inactivated Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe Pet Inactivated Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Pet Inactivated Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific Pet Inactivated Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Pet Inactivated Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America Pet Inactivated Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Pet Inactivated Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Pet Inactivated Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Pet Inactivated Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global Pet Inactivated Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Pet Inactivated Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global Pet Inactivated Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global Pet Inactivated Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Pet Inactivated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pet Inactivated Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Pet Inactivated Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Pet Inactivated Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pet Inactivated Vaccine Market Size by Country (M USD)
Figure 11. Pet Inactivated Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Pet Inactivated Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Pet Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pet Inactivated Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pet Inactivated Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pet Inactivated Vaccine Market Share by Type
Figure 18. Sales Market Share of Pet Inactivated Vaccine by Type (2019-2025)
Figure 19. Sales Market Share of Pet Inactivated Vaccine by Type in 2023
Figure 20. Market Size Share of Pet Inactivated Vaccine by Type (2019-2025)
Figure 21. Market Size Market Share of Pet Inactivated Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pet Inactivated Vaccine Market Share by Application
Figure 24. Global Pet Inactivated Vaccine Sales Market Share by Application (2019-2025)
Figure 25. Global Pet Inactivated Vaccine Sales Market Share by Application in 2023
Figure 26. Global Pet Inactivated Vaccine Market Share by Application (2019-2025)
Figure 27. Global Pet Inactivated Vaccine Market Share by Application in 2023
Figure 28. Global Pet Inactivated Vaccine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Pet Inactivated Vaccine Sales Market Share by Region (2019-2025)
Figure 30. North America Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Pet Inactivated Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Pet Inactivated Vaccine Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Pet Inactivated Vaccine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Pet Inactivated Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Pet Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Pet Inactivated Vaccine Sales Market Share by Region in 2023
Figure 44. China Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Pet Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Pet Inactivated Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Pet Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Pet Inactivated Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Pet Inactivated Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Pet Inactivated Vaccine Production Market Share by Region (2019-2025)
Figure 62. North America Pet Inactivated Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Pet Inactivated Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Pet Inactivated Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 65. China Pet Inactivated Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Pet Inactivated Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Pet Inactivated Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Pet Inactivated Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Pet Inactivated Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Pet Inactivated Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Pet Inactivated Vaccine Market Share Forecast by Application (2025-2032)
